Research paper

Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays

View original item

About this item

Title
Infliximab and adalimumab concentrations and anti-drug antibodies in inflammatory bowel disease control using New Zealand assays
Content partner
University of Otago
Collection
Otago University Research Archive
Description

Therapeutic drug monitoring of anti-tumour necrosis factor (TNF) drugs and anti-drug antibodies (ADA) is now recommended in the treatment of inflammatory bowel disease. However, assay types and drug concentration thresholds are still debated. To correlate inflammatory bowel disease activity in a New Zealand cohort with trough concentrations of infliximab and adalimumab, and ADA using locally developed competitive-binding enzyme-linked immunosorbent assays (ELISA) to establish threshold concen...

Format
Research paper
Research format
Scholarly text / Journal article
Thesis level
Article
Date created
2019-04
Creator
Barclay, Murray L / Karim, Shwan / Helms, Esther T Johanna / Keating, Paula E / Hock, Barry / Stamp, Lisa K / Schultz, Michael
URL
https://hdl.handle.net/10523/28682
Related subjects
Adalimumab - blood / Adalimumab - therapeutic use / Adolescent / Adult / Aged / Anti-Inflammatory Agents - blood / Anti-Inflammatory Agents - therapeutic use / Antibodies, Neutralizing - blood / Binding, Competitive / Drug Monitoring - methods / Enzyme-Linked Immunosorbent Assay / Female / Gastrointestinal Agents - blood / Gastrointestinal Agents - therapeutic use / Humans / Inflammatory Bowel Diseases - drug therapy / Infliximab - blood / Infliximab - therapeutic use / Male / Middle Aged / New Zealand / ROC Curve / Tumor Necrosis Factor-alpha - antagonists & inhibitors / Young Adult

What can I do with this item?

Check copyright status and what you can do with this item

Check information

Report this item

If you believe this item breaches our terms of use please report this item

Report this item

DigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 21 August 2024, and updated 09 October 2024.
Learn more about how we work.

Share

What can I do with this item?

You must always check with University of Otago to confirm the specific terms of use, but this is our understanding:

Research icon

Non-infringing use

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

NZ Copyright law does not prevent every use of a copyright work. You should consider what you can and cannot do with a copyright work.

No sharing icon

No sharing

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

You may not copy and/or share this item with others without further permission. This includes posting it on your blog, using it in a presentation, or any other public use.

No modifying icon

No modifying

You are not allowed to adapt or remix this item into any other works.

You are not allowed to adapt or remix this item into any other works.

No commercial use icon

No commercial use

You may not use this item commercially.

You may not use this item commercially.

View original item

What can I do with this item?

Check copyright status and what you can do with this item

Check information

Report this item

If you believe this item breaches our terms of use please report this item

Report this item

DigitalNZ brings together more than 30 million items from institutions so that they are easy to find and use. This information is the best information we could find on this item. This item was added on 21 August 2024, and updated 09 October 2024.
Learn more about how we work.

Share

Related items

Loading...